Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01646021 |
|---|---|
| Brief Title: | Study of Ibrutinib (a Bruton's Tyrosine Kinase Inhibitor), Versus Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy |
| First Submitted : | July 18, 2012 |
| First Submitted that Met QC Criteria : | July 18, 2012 |
| First Posted : | July 20, 2012 (Estimate) |
| Results First Submitted : | June 2, 2016 |
| Results First Submitted that Met QC Criteria : | January 11, 2017 |
| Results First Posted : | March 1, 2017 |
| Last Update Submitted that Met QC Criteria : | December 15, 2017 |
| Last Update Posted : | January 19, 2018 |